1. Arterial and venous whole blood and plasma histamine concentrations and eosinophil and basophil counts were determined in five patients with acute severe asthma who had not previously received steroid therapy, in five who had been maintained on steroid therapy and in a control group of nine patients with acute non-respiratory illnesses.
Introduction
In a previous study (Bruce, Weatherstone, Seaton & Taylor, 1976) we demonstrated a raised histamine concentration in the plasma of patients with acute severe asthma and a fall in whole blood histamine concentrations in such patients when treated with high-dose corticosteroids. However, the plasma histamine concentrations of patients with other chest illnesses were also raised, when compared with those of normal subjects. The present study was planned to investigate histamine metabolism in severe asthma further, by studying whole blood histamine in relation to leucocyte counts and arteriovenous histamine differences. In addition, the time course of the response to corticosteroids was investigated. 
Subjects and methods
All subjects gave informed consent and the protocol was approved by the area Ethical Committee. Ten patients admitted with acute severe asthma formed the study group. All satisfied our criteria for severity, namely a pulse > 1 lO/min, peak flow rate <25% of that predicted, Pa,o, 9.3 kPa (70 mmHg) or less, and previous or subsequent demonstration of widely variable airways obstruction. Five of these patients were being treated with oral prednisone and five were not. Ten patients admitted to hospital with acute nonrespiratory illnesses served as a control group, though one was subsequently excluded as he developed a drug allergy on the day of study. The control group had arterial and venous blood samples taken on admission. The asthmatic group had arterial and venous samples taken on admission and at 1, 6 and 24 h after the start of treatment, and, in addition, venous samples were taken at 0.5, 2, 4 and 12 h after the start of treatment. Venous samples were taken from a central venous pressure line after appropriate flushing with blood.
Samples for histamine were taken as described previously (Bruce et al., 1976 ) and stored at -20°C until analysed. Arterial and venous blood samples were placed in sequestrene bottles and leucocyte counts performed within 12 h with a model S counter (Coulter Electronics Ltd, Harpenden, Herts., U.K.). Blood films were made for each sample and stained with Wright's stain in a Haematek staining machine (Ames Co., Stoke Poges, Bucks., U.K.) Differential leucocyte counts were performed on 5 0 0 consecutive cells by one technician and the absolute number/mm3 was calculated.
Whole blood and plasma were analysed for histamine by a modification of the method of Miller, McCord, Sanda, Bourne & Melmon (1970) , described in detail previously (Bruce et al., 1976). The method is based on that of Snyder, Baldessarini & Axelrod (1966) , in which histamine is converted into 1-methylhistamine, in the presence of histamine methyltransferase (EC 2.1.1.8), with S-adenosylmethionine as the methyl donor. We used S-adenosylmethionine ( n~e t h y l -~H~) of high specific radioactivity (500 mCi/mmol, The Radiochemical Centre, Amersham, Bucks., U.K.), added human y-globulin to our aqueous standards to achieve approximate quantitative identity with plasma, and used fresh pig brain as the purified enzyme source, to increase the sensitivity of the method. If any plasma samples showed evidence of haemolysis they were rejected. All the asthmatic patients received the same treatment, namely 1 g of hydrocortisone intravenously initially, followed by an infusion of 0.5 g every 6 h, plus 40 mg of prednisone orally daily, together with intravenous salbutamol or aminophylline or inhaled salbutamol and oxygen as necessary. All made an uncomplicated recovery over the subsequent 2 weeks. 
Statistical methods
Student's t-tests were applied to the groups and the probabilities of the differences between arterial and venous blood, and controls and asthmatics being statistically significant were calculated. Correlation coefficients between basophil and eosinophil counts and blood and plasma histamine concentrations were calculated for all groups. The effect of time was considered by measuring, in venous blood only, the linear regression of each measurement and correlating with time.
Results

Arteriovenous differences
Arteriovenous differences for histamine, basophils and eosinophils were examined in the three groups (Tables 3, 4, 5 , 6 and 7) . No statistically significant differences between arterial and venous blood were found.
Asthmatic patients compared with controls (Table 8 ). All initial mean measurements were higher in asthmatic patients than in controls except for arterial plasma histamine in those asthmatics who had been on corticosteroids. Statistically significant differences (P = 0.05 or less) were found for both arterial ( P < 0.025) and venous ( P < 0.01) whole blood histamine concentrations, for arterial (P<O-OOl) and venous (P<O.O25) eosinophils, and for arterial (P < 0.05) and venous ( P < 0.05) basophils, when values for the asthmatic patients who had not been on corticosteroids were compared with those for the controls. For asthmatic patients on steroids, only the venous blood basophil count was significantly higher than that in controls ( P < 0.05).
Effect of previous steroid therapy in asthmatic patients. When the two groups of asthmatic patients were compared (Tables 4, 5, 6 and 7) all initial mean values were higher in the group who had not received steroids before admission, except the venous basophil count, which was marginally lower, but these results did not reach significance.
After 6 h, the mean arterial whole blood ( P < 0.02) and plasma ( P < 0.05) histamine concentrations were higher in the patients who had not received steroids.
Correlation among histamine measurements and cell counts. Correlation coefficients between eosinophil and basophil counts and plasma and whole blood histamine concentrations in venous and arterial blood were calculated. There was a significant positive correlation between arterial and venous whole blood histamine values and the respective eosinophil and basophil counts in both groups of asthmatic patients (Table 8 ). The venous plasma histamine was positively correlated with the eosinophil count in both groups of asthmatic patients, but with the basophil count only of those who had received steroids. The arterial plasma histamine was not significantly correlated with the basophil count of either group, but was correlated with the eosinophil count in those who had received steroids.
Mean histamine content of the basophil
As most of the histamine in blood resides in the basophils the mean histamine content per basophil was calculated by dividing the whole blood histamine by the basophil count. The mean histamine content per basophil of all samples, arterial and venous, controls and asthmatic patients was 1.1 pg (range 0.45-5.6 pg), equivalent to 0.01 pmol/basophil. The mean histamine content per basophil was calculated for the various sub-groups but no significant differences were found. The mean number of molecules of histamine per basophil is 6.0 x 109.
Effect of treatment
The change in each measurement with time, which is presumed to be the effect of treatment, was expressed for venous blood by measuring the linear regression and correlating with time. There was a statistically significant negative correlation with time for all measurements in both groups of asthmatic patients except for the plasma histamine in the 'no steroid' group ( Table 9) .
Discussion
There is much experimental support for the concept that in asthma bronchoconstrictor substances are liberated from tissue mast cells and act either directly on the bronchi or indirectly via vagal receptors to cause the changes associated with the asthmatic attack (Katz & Cohen, 1941; Schild, 1956; Brocklehurst, 1960) . In spite of this, studies of histamine in asthmatic patients have shown conflicting results, and in our previous study (Bruce et al., 1976) , using sensitive assay techniques, we found that plasma histamine concentrations were significantly higher in patients during severe attacks of asthma than in normal subjects, but were not significantly higher than in patients with other respiratory illnesses.
In this study we sampled arterial blood to see if histamine liberated in the lung during severe attacks of asthma could be detected before it had passed through the circulation. However, we were unable to show higher concentrations of either whole blood or plasma histamine in arterial than in venous blood. Whether this means that liberated histamine is metabolized rapidly in the lung, a definite possibility (Schayer & Cooper, 1956; Beall & van Arsdel, 1960) , or that large amounts of histamine are not liberated from the lung in severe asthma, is not clear. Raised arterial plasma histamine concentrations have been demonstrated after bronchial challenge with specific antigen in dogs (Chiesa, Dain, Meyers, Kessler & Gold, 1975) , indicating that histamine is liberated in that situation. Our patients had all been ill for several hours and it may well have been that higher arterial histamine concentrations would have been found at an earlier stage in their illness, before mast cells became depleted.
In the earlier literature (summarized by Lindell & Westling, 1966) whole blood histamine values were usually found to be moderately elevated during asthmatic attacks. Most of these reports pre-dated the maintenance treatment of asthmatic patients with steroids; in contrast to our previous study, in which asthmatic patients were not divided into steroid-and non-steroid-treated groups, we now find, for patients not receiving steroids, a significantly higher concentration of whole blood histamine than in controls, thus confirming the earlier observation. The statistically significant positive correlation in the asthmatic patients between arterial and venous whole blood histaniine concentrations, venous plasma concentrations and the leucocyte counts agree with the work of Code & Mitchell (1957), who, in a classical paper, found a positive correlation of whole blood histamine concentrations and the eosinophil and basophil counts in normal volunteer subjects given cortisone, 200 mg/day for 3 days. The correlation between basophil counts and whole blood histamine concentrations both in controls and asthmatic patients at all stages of the study also supports previous studies that suggest that the histamine is largely in basophils (Porter & Mitchell, 1970; Beaven, 1976) .
For asthmatic patients not previously on steroids, the venous plasma histamine concentration is significantly higher than the normal range (4.01 ? SD 3.4 nmol/l, P < 0-OOI), thus confirming our earlier finding (Bruce et al., 1976) . For asthmatic patients who have been previously treated with steroids the values are higher but not significantly so (0.3 > P > 0.2). The plasma histamine concentration of the control group of this study is significantly higher than the normal range (0.05 > P > 0.02), thus supporting our earlier suggestion that illness per se, when severe enough to warrant hospital admission, causes an increased venous plasma histamine concentration.
We have shown a significant eosinophilia in acute severe asthma, though it is somewhat surprising that this was not higher in view of its reported relationship to the severity of the condition (Horn, Robin, Theodore & Van Kessell, 1975 ) and the suggested homeostatic role of the eosinophil in histamine-mediated reactions. It may be that circulating eosinophils are only a poor indicator of tissue levels of the cell. Certainly sputum eosinophilia is an almost invariable accompaniment of asthma, whatever the blood count.
As with eosinophils and histamine, so with basophils we found a slight elevation in the number in blood of severe asthmatic patients, though there was considerable variation and this increase was not significant in the arterial blood of patients who had previously been on steroids. Kimura, Moritani & Tanizaki (1973) have found elevated basophil counts in asthmatic patients before an attack, with reduction during the attack. They also reported a sputum basophilia during attacks, subsiding afterwards (Kimura, Tanizaki, Saito, Takahashi, Uedo & Sato, 1975) .
Basophilia has also been reported in hay fever (Hirsch & Kalbfleisch, 1976) and in subjects sensitized to novobiocin (Shelley, 1963) . However, urticaria seems to be associated with basopenia (Rorsman, 1962) . It seems likely that the basophil is the circulating form of the tissue mast cell, and it may well be that much less variation occurs in blood than in tissue numbers. Studies of mast cell populations in allergic disease have also given conflicting results, possibly due to difficulties in identifying the cell when it has degranulated. Salvato (1968) showed a decrease in mast cells in asthmatic bronchi but Connell (1973) reported their increase in the nasal mucosa in perennial rhinitis.
The most striking finding in our study was the fall in number of circulating basophils and eosinophils and in whole blood histamine concentration after the start of therapy. All had fallen to very low values within 4-6 h of starting therapy with hydrocortisone and bronchodilators. This time course of response is the same as that described for eosinophil counts after adrenocorticotrophin by Thorn, Forsham, Prunty & Hills (1948) and that after oral prednisone in three patients by Noah & Brand (1957) . By contrast, plasma histamine showed a less clear decline, though by 24 h it was significantly lower than before treatment, as in our previous study. It is likely that this effect on cells and histamine was related to the hydrocortisone, though sympathetic stimulants (Koch-Weser, 1968) and aminophylline (Ohman, Lawrence & Lowell, 1972 ) also have been shown to produce eosinopenia.
It seems likely from the various reported studies that histamine is liberated from mast cells during the early stages of an asthmatic attack, acting on a receptor which is usually more sensitive to it, than that of the normal subject. By the time the attack has developed to the severity at which we studied it, it is probable that tissue mast cells are becoming depleted of histamine and relatively little can be found in the circulation. Nevertheless, therapy with corticosteroids is associated with a rapid fall in basophils and blood histamine and a slower fall in plasma histamine and this may be one way in which steroids help in the control of the condition. In this context it should be noted that arterial and venous plasma histamine concentrations were generally higher initially, and during treatment, in the patients not previously on steroids than in those who had been, although statistical significance was only found at 6 h.
In this study and in our earlier study we have altogether investigated histamine metabolism in 20 patients with severe acute asthma. Of these, eight have had initial venous plasma histamine values greater than 10.8 nmol/l, the normal mean plus 2 SD. The therapeutic question thus arises as to whether, in this &oup of patients, HI-receptor antagonists might not exert a beneficial effect.
In the combined control groups of our two studies only three of 19 patients had initial venous plasma histamine values above 10.8 nmol/l, as compared with eight' of 20 asthmatic patients (0.1 > P > 0.05). The mean venous plasma histamine concentration of the combined controls was 6.5 nmol/l, as compared with 9.9 nmolh for the asthmatic patients (0.1 > P > 0.05) and 4.0 nmol/l for normal subjects. It seems likely therefore that severe illness per se causes an elevation of plasma histamine concentration and that severe asthmatic patients have an even greater concentration, but the desired statistical level of proof is not yet available.
